Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment

Silvia Bellesi; Michela Sali; Maria Elisa Maiolo; Maria Del Carmen Pereyra Boza; Eleonora Alma; Ivana Palucci; Federica Fatone; Flavio De Maio; Marcello Viscovo; Francesco D'Alo'; Valerio De Stefano; Stefan Hohaus; Maurizio Sanguinetti

doi:10.1080/10428194.2022.2032042

Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment

Silvia Bellesi, Michela Sali, Maria Elisa Maiolo, Maria Del Carmen Pereyra Boza, Eleonora Alma, Ivana Palucci, Federica Fatone, Flavio De Maio, Marcello Viscovo, Francesco D'Alo', Valerio De Stefano, Stefan Hohaus, Maurizio Sanguinetti

Research output: Contribution to journal › Article

Abstract

N/A

Original language	English
Pages (from-to)	1-5-5
Journal	LEUKEMIA & LYMPHOMA
DOIs	https://doi.org/10.1080/10428194.2022.2032042
Publication status	Published - 2022

Keywords

CD19+ B lymphocytes
COVID-19
Lymphoma
anti-CD20 immunotherapy
mRNA vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2022.2032042

Cite this

Bellesi, S., Sali, M., Maiolo, M. E., Pereyra Boza, M. D. C., Alma, E., Palucci, I., Fatone, F., De Maio, F., Viscovo, M., D'Alo', F., De Stefano, V., Hohaus, S., & Sanguinetti, M. (2022). Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment. LEUKEMIA & LYMPHOMA, 1-5-5. https://doi.org/10.1080/10428194.2022.2032042

@article{095fe3c7ca494de5a155c5abc3cc3e7c,

title = "Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment",

abstract = "N/A",

keywords = "CD19+ B lymphocytes, COVID-19, Lymphoma, anti-CD20 immunotherapy, mRNA vaccine, CD19+ B lymphocytes, COVID-19, Lymphoma, anti-CD20 immunotherapy, mRNA vaccine",

author = "Silvia Bellesi and Michela Sali and Maiolo, {Maria Elisa} and {Pereyra Boza}, {Maria Del Carmen} and Eleonora Alma and Ivana Palucci and Federica Fatone and {De Maio}, Flavio and Marcello Viscovo and Francesco D'Alo' and {De Stefano}, Valerio and Stefan Hohaus and Maurizio Sanguinetti",

year = "2022",

doi = "10.1080/10428194.2022.2032042",

language = "English",

pages = "1--5--5",

journal = "LEUKEMIA & LYMPHOMA",

issn = "1042-8194",

publisher = "Taylor & Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL: [email protected], [email protected], INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245",

}

Bellesi, S, Sali, M, Maiolo, ME, Pereyra Boza, MDC, Alma, E, Palucci, I, Fatone, F, De Maio, F, Viscovo, M, D'Alo', F , De Stefano, V , Hohaus, S & Sanguinetti, M 2022, 'Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment', LEUKEMIA & LYMPHOMA, pp. 1-5-5. https://doi.org/10.1080/10428194.2022.2032042

TY - JOUR

T1 - Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment

AU - Bellesi, Silvia

AU - Sali, Michela

AU - Maiolo, Maria Elisa

AU - Pereyra Boza, Maria Del Carmen

AU - Alma, Eleonora

AU - Palucci, Ivana

AU - Fatone, Federica

AU - De Maio, Flavio

AU - Viscovo, Marcello

AU - D'Alo', Francesco

AU - De Stefano, Valerio

AU - Hohaus, Stefan

AU - Sanguinetti, Maurizio

PY - 2022

Y1 - 2022

N2 - N/A

AB - N/A

KW - CD19+ B lymphocytes

KW - COVID-19

KW - Lymphoma

KW - anti-CD20 immunotherapy

KW - mRNA vaccine

KW - CD19+ B lymphocytes

KW - COVID-19

KW - Lymphoma

KW - anti-CD20 immunotherapy

KW - mRNA vaccine

UR - http://hdl.handle.net/10807/206251

U2 - 10.1080/10428194.2022.2032042

DO - 10.1080/10428194.2022.2032042

M3 - Article

SN - 1042-8194

SP - 1-5-5

JO - LEUKEMIA & LYMPHOMA

JF - LEUKEMIA & LYMPHOMA

ER -

Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this